AutoFlow feature allows the user to set the
dialysate flow to either 1.5 times or 2 times
the blood flow in steps of 100 ml/min.3
During idle periods, the 2008T machine will
automatically run dialysate flow at 300 ml/min
to conserve dialysate or it may be manually
set to as low as 0 ml/min.
Ensures the most economical use of dialysate
while maintaining an optimal dialysis dose—
potential savings of up to 30% with no impact
on Kt/V attainment.4
   
3Blood flow and dialysate flow values are determined by physician
 prescription.
4Kult J, Stapf, E. “Changing Emphasis in Modern Hemodialysis
 Therapies: Cost-effectiveness of Delivering Higher Doses of Dialysis.”
 The International Journal of Artificial Organs 30(7):577-582, 2007

 

 

 

Fresenius Logo

Caution: Federal (US) law restricts these devices to sale by or on the order of a physician.

Note: Read the Instructions for Use for safe and proper use of these devices. For a complete description of hazards, contraindications, side effects and precautions, see full package labeling at www.fmcna.com.

This site is intended for visitors from the United States.

© 2013-2017, Fresenius Medical Care, All Rights Reserved. Fresenius Medical Care, the triangle logo, Fresenius Renal Technologies, 2008, bibag, DIASAFE, Fresenius Polysulfone, Twister, Crit-Line, CLiC, and Clinical Data eXchange (CDX) are trademarks of Fresenius Medical Care Holdings, Inc., or its affiliated companies. Citrasate is a registered trademark of Advanced Renal Technologies in the United States and is used under license from Advanced Renal Technologies. All other trademarks are the property of their respective owners. P/N 102054-01 Rev C 10/2017